Employees department of Public Health



Professor H.J. de Koning MD, PhD, epidemiologist - click to enlarge
Professor H.J. de Koning MD, PhD, epidemiologist
Professor of Public Health & Screening Evaluation
Biography Research Interests Projects Publications Working papers Memberships Contact

    Publicaties

    1. Koning, HJ de, Meza R, Plevritis SK, Ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, Van Rosmalen J, Choi SE, Pinsky PF, De Gonzalez AB, Berg CD, Black WC, Tammemagi MC, Hazelton WD, Feuer EJ, and McMahon PM. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force. Annals of Internal Medicine 160, no. 5 (2014): 311-20

    2. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, De Koning HJ, Auvinen A; ERSPC Investigators. “Prostate-cancer mortality at 11 years of follow-up”. N Engl J Med. 2012 Mar 15;366(11):981-90

    3. Klaveren RJ van, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, Iersel CA van, Bergh KAM van de, Westeinde SC van ‘t, van der Aalst C, Thunissen E, Xu DM, Wang Y, Zhao Y, Gietema HA, De Hoop B-J, Groen HJM, Bock GH, Van Ooijen P, Weenink C, Verschakelen J, Lammers JWJ, Timens W, Willebrand D, Vink A, Mali WPTM, De Koning HJ. Management of lung nodules detected by Volume CT Scanning. N Eng J Med2009; 361 (123): 2221-2229

    4. Schoonen, HM, Essink-Bot M-L, Van Agt HM, Wildschut HI, Steegers EA, De Koning HJ. Informed decision-making about the fetal anomaly scan: what knowledge is relevant? Ultrasound Obstet Gynecol. 2011 Jun;37(6):649-57

    5. Bunge, EM, Habbema JD, De Koning HJ. A randomised controlled trial on the effectiveness of bracing patients with idiopathic scoliosis: failure to include patients and lessons to be learnt. Eur Spine J. 2010 May; 19(5):747-53

    6. Heijnsdijk EAM, Wever EM, Auvinen A, Hugosson J, Ciatto S, Nelen V, Kwiatkowski M, Villers A, Páez A, Moss SM, Zappa M, Tammela TLJ, Mäkinen T, Carlsson S, Korfage IJ, Essink-Bot M-L, Otto SJ, Draisma G, Bangma CH, Roobol MJ, Schröder FH,, De Koning HJ. Quality-of-Life Effects of Prostate-Specific Antigen Screening. N Engl J Med 2012; 367, no. 7: 595-605

    7. Louwers ECFM, Korfage IJ, Affourtit MJ, Scheewe DJH, Van De Merwe MH, Vooijs-Moulaert AFSR, Van Den Elzen APM, Jongejan MH, Ruige M, Manaï BHAN, Looman CWN, Bosschaart AN, Teeuw AH, Moll HA, De Koning HJ. Effects of Systematic Screening and Detection of Child Abuse in Emergency Departments. Pediatrics 130, no. 3 (2012): 457-64

    8. Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy W, Boer R, Gorlova O, Gazelle GS, Kimmel M, McMahon PM, De Koning HJ,Feuer EJ. Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975-2000. Journal of the National Cancer Institute 104, no. 7 (2012): 541-48

    9. Saadatmand SM, Tilanus-Linthorst MA, Rutgers EJT, Hoogerbrugge N, Oosterwijk JC, Tollenaar RAEM, Hooning M, Loo CE, Obdeijn IM, Heijnsdijk EAM, De Koning HJ. Cost-Effectiveness of Screening Women with Familial Risk for Breast Cancer with Magnetic Resonance Imaging. Journal of the National Cancer Institute2013;105, no. 17: 1314-21.

    10. Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, De Koning HJ, Steyerberg EW, Meza R. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. PLoS Med. 2017 Apr 4;14(4):e1002277. doi: 10.1371/journal.pmed.1002277. eCollection 2017 Apr.